hero-line-left hero-line-top

Powering precision medicine. Delivering the best cancer care.

Syapse enables healthcare providers to bring precision medicine to every cancer patient today.

icon-line icon

Aurora Health Care

launched a precision medicine program that will bring new treatment options to cancer patients.

Learn how
icon-line icon

Providence St. Joseph Health

scaled precision medicine and clinical trials matching across their community and research clinics.

Learn how
icon-line icon

Henry Ford Cancer Institute

uses real-world evidence from a national data-sharing network to improve cancer care in Michigan.

Learn how

Our health system customers

All customers
Syapse enables us to share robust, real-world evidence with other community health systems and research practices, linking us with our peers while keeping patient data secure. Together, we’re creating a new standard for evidence-driven precision cancer care.”
Thomas Brown, MD, MBA
Thomas Brown, MDMBA
Executive Director of the Swedish Cancer Institute

In the news

Amgen taps Syapse to infuse real-world data into its cancer clinical trial designs

5/2/19 - Precision medicine company Syapse has launched a collaboration with its one-time Big Pharma benefactor Amgen, with the goal of mining real-world evidence for insights into cancer drug development. Together, Amgen and Syapse will develop observational research analytics aimed at assessing outcomes in areas of unmet need—starting by identifying existing patients within Syapse’s health network that may be eligible for clinical trials, and then bringing those studies to nearby sites.



Syapse Expands Security Posture with HITRUST Certification

Patient data collected from electronic health records, molecular testing and patient reported outcomes is powering many of the most exciting…


Let’s talk

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.